["{\n\"step_by_step_thinking\": \"The relevant documents describe the pharmacokinetics of intravenously administered L-5-hydroxytryptophan in man. It is mentioned that carbidopa, an L-aromatic amino acid decarboxylase inhibitor, was used to pretreat patients for one week before administering 5-hydroxytryptophan. This suggests that DOPA and 5-Hydroxytryptophan are indeed acidic precursors of brain amines, as carbidopa inhibits the conversion of these amino acids into their respective neurotransmitters.\",\n\"answer_choice\": \"B\""]